LifeX Labs is a purpose-built space for collaboration, creating a culture of excellence and resilience, mentoring, expanding networks and company building.


Exceptional start-up companies are invited to move their operations to our foundry in Pittsburgh. Here, companies realize their vision, hone their skills and gather momentum to bring their products to the marketplace.

There is an application process to gain acceptance into the Labs program, a transparent ‘healthy company checklist’ against which companies are evaluated, and decisions made by our Active Management Group. Upon acceptance, early stage companies are asked to contribute:

  • $350 for a desk

  • $650 for a small office with 2 desks

  • $1400 for a large office with 6 desks

  • 1% equity which is non-dilutable until after Series A to create alignment.

  • Later stage companies can gain access to the Labs programs (inquire)

In exchange, companies get 20 hours per month of mentoring, world-class space, trusted service providers, access to our networks for financing, and a culture of resilience.

In the LifeX Labs, companies may receive convertible-note financing upon entry so and benefit from being co-located with an experienced team of scientific entrepreneurs.

There’s a carefully curated program of support, assisting with everything needed to build a significant company including company formation, recruiting, financing, operations, commercial operations, partnering, exit and more.

The labs are where pioneering science meets commercial expertise. It's where we nurture the next generation of biotechnology companies.  


Our Founder and CEO selected Pittsburgh as the home of our Labs and of our Capital Fund based on a national survey of hubs of innovation. Pittsburgh has the ideal depth and breadth of various silos of expertise that can form novel convergent solutions for the future.



Every start-up considered for the LifeX Labs goes through a thorough evaluation process using our “healthy company checklist” and a team evaluation (see links above).


We're looking for groundbreaking ideas that have the potential to meet a global unmet health need.

Our key areas of focus include:


LifeX completely changed the trajectory of my company, Peptilogics. Dr. Stephan applied the full spectrum of his experiences and network and we have now closed our Series A with one of the world’s most successful and well-known investors - Peter Thiel. Dr. Stephan has become a trusted mentor and has demonstrated time and again that he’ll do what it takes to help make Peptilogics successful.
— Jonathan Steckbeck, PhD - Founder, Peptilogics




To manage our large portfolio effectively, we lead, or co-lead, investments. It means we can drive the terms, and avoid diluting our resources across the portfolio.

A good example of this is Peptilogics; LifeX’s CEO, Dr Dietrich Stephan identified the early-stage biotechnology company as an excellent solution to the large and growing antibiotic resistant superbug pandemic.

Stephan then joined the company as Chairman of the Board and put the team and financing in place. This unlocked a syndicate of top-tier investors, as well as attracting a truly world class management team. The company has now been granted QIDP status by FDA, is in human clinical trials, and is recognized a novel solution to an emerging global problem. 

Peptilogics is indicative of the thinking, commitment and support that an innovator can expect from LifeX Labs, both in terms of drive and science-based business acumen.